STM

STMicroelectronics is in the depths of a cyclical downturn, and the numbers are stark. Revenue has fallen for two straight years from the FY2023 peak of $17.3B to $11.8B in FY2025 (-11.1% YoY), while net income has collapsed 89.3% to just $166M — a fraction of the $4.21B earned in FY2023. Operating margin has compressed to 1.5% and net margin to 1.4%, dragging ROE down to a token 0.9%. Gross margin held at 33.9% but fell 23.4% in absolute gross profit, consistent with the volume and pricing pressure typical of an analog/microcontroller maker working through customer inventory destocking. The trailing P/E of 435x is meaningless on trough earnings; the more telling read is P/S of 5.9x and roughly 3.9x book ($17.8B equity over 889M shares ≈ $20/share) — full multiples for a company earning almost nothing right now.

What keeps this from being a sell is balance-sheet quality and the cyclical (not structural) nature of the weakness. Liabilities/equity is a conservative 0.37x, cash grew 24.3% to $2.84B, long-term debt is modest at $1.83B and the current portion fell 69.9%. Operating cash flow of $2.15B still comfortably funded $1.03B of capex, $367M of buybacks and $321M of dividends, and R&D was protected (-1.6% to $2.04B) — management is investing through the trough rather than cutting into the franchise. Current assets ($11.3B) dwarf current liabilities ($3.35B). This is a financially sound business enduring a downcycle, not one in distress.